Compare LUV & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | EXAS |
|---|---|---|
| Founded | 1967 | 1995 |
| Country | United States | United States |
| Employees | N/A | 7200 |
| Industry | Air Freight/Delivery Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 19.7B |
| IPO Year | 1995 | 2000 |
| Metric | LUV | EXAS |
|---|---|---|
| Price | $52.09 | $103.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 18 | 18 |
| Target Price | $46.19 | ★ $85.64 |
| AVG Volume (30 Days) | ★ 10.5M | 2.1M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | 3.95 | ★ 80.32 |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | ★ $4,144,000.00 |
| Revenue This Year | $14.13 | $15.18 |
| Revenue Next Year | $5.00 | $12.46 |
| P/E Ratio | $65.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.82 | $38.88 |
| 52 Week High | $55.11 | $103.87 |
| Indicator | LUV | EXAS |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 67.49 |
| Support Level | $49.80 | $103.21 |
| Resistance Level | $55.11 | $103.42 |
| Average True Range (ATR) | 1.88 | 0.34 |
| MACD | -0.17 | -0.13 |
| Stochastic Oscillator | 49.64 | 67.53 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In early 2026, Southwest will modify its cabins to offer some rows with extra legroom and will update its ticketing process and merchandising to offer assigned seats and more fare categories, including a basic economy class that will more directly compete with other airlines' offerings and appear for the first time in travel aggregators' search results.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.